KEVIN RAIDY

Profile

First Name

: KEVIN

Middle Name

:

Last Name

: RAIDY

Related Companies
Titles
Company Name
Related People
DIRECTOR
SEMMA THERAPEUTICS, INC.
DANIEL AUERBACH, MITCH FINER, MITCHELL FINER, MARK FISHMAN, TODD FOLEY, STEPHEN KNIGHT, ROBERT MILLMAN, WILLIAM SAHLMAN, BASTIANO SANNA, JIM SCOPA, ELIZABETH STONER, KINGSLEY TAFT
DIRECTOR
PLIANT THERAPEUTICS, INC.
SUZANNE BRUHN, BERNARD COULIE, GAYLE CROWELL, KEITH CUMMINGS, JOHN CURNUTTE, NEIL EXTER, CHARLES HOMCY, BARBARA HOWES, HOYOUNG HUH, JOHANNES HULL, ERIC LEFEBVRE, SMITAL SHAH
EXECUTIVE OFFICER
COWEN HEALTHCARE INVESTMENTS III LP
N/A CHI ADVISORS LLC, N/A COWEN HEALTHCARE INVESTMENTS III GP LLC
EXECUTIVE OFFICER
CHI EF III LP
N/A CHI ADVISORS LLC, N/A COWEN HEALTHCARE INVESTMENTS III GP LLC
DIRECTOR
ESCIENT PHARMACEUTICALS INC
ALAIN BARON, MARCUS BOEHM, KATHLEEN GLAUB, KATHLEEN SEREDA GLAUB, JOSHUA GRASS, JASON HAFLER, PETER HIRTH, JEENJOO KANG, AARON MISHEL, ANDREW SCHWAB, ROBERT TJIAN, CHARLES ZUKER
DIRECTOR
ARO BIOTHERAPEUTICS CO
ELIZABETH ANDERSON, SUSAN B DILLON, MITTIE DOYLE, SAAN-CHIRAG GANDHI, SCOTT GREENBERG, DANIEL JANSE, MARK LAURENZI, MARK V. LAURENZI, JESS LIFTON, CHRISTOPHER MIRABELLI, KARYN O-NEIL, BRUCE PEACOCK, MARTEN STEEN
EXECUTIVE OFFICER
COWEN HEALTHCARE INVESTMENTS IV LP
N/A CHI ADVISORS LLC, N/A COWEN HEALTHCARE INVESTMENTS IV GP LLC
EXECUTIVE OFFICER
CHI EF IV LP
N/A CHI ADVISORS LLC, N/A COWEN HEALTHCARE INVESTMENTS III GP LLC
DIRECTOR
LATIGO BIOTHERAPEUTICS, INC.
NIMA FARZAN, TIM LUGO, DEBORAH PALESTRANT, BETH SEIDENBERG, NANCY STAGLIANO, JIM TANANBAUM, TIM WALBERT
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-01-28 
2022-12-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-13 
2022-12-20
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-09-20 
2022-12-20
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-09-20 
2022-11-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-14 
2021-12-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-09-28
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-09-20 
2021-09-28
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-09-20 
2021-06-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-04-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2021-01-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2020-09-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-19 
2020-09-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-19 
2020-03-11
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-12-19 
2020-01-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-12-19 
2019-09-25
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2019-09-16 
2019-09-24
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2019-09-16 
2019-02-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-27 
2018-07-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-10 
2018-07-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-10 
2017-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-27